Literature DB >> 16836648

Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Iole Macchia1, Marie-Claire Gauduin, Amitinder Kaur, R Paul Johnson.   

Abstract

Circulating CD4+ CD8+ T lymphocytes have been described in the peripheral blood of humans and several animal species. However, the origin and functional properties of these cells remain poorly understood. In the present study, we evaluated the frequency, phenotype and function of peripheral CD4+ CD8+ T cells in rhesus macaques. Two distinct populations of CD4+ CD8+ T cells were identified: the dominant one was CD4hi CD8lo and expressed the CD8alphaalpha homodimer, while the minor population was CD4lo CD8hi and expressed the CD8alphabeta heterodimer. The majority of CD4hi CD8alphalo T cells exhibited an activated effector/memory phenotype (CCR5lo CD7- CD28- HLA-DR+) and expressed relatively high levels of granzyme B. Intracellular cytokine staining assays demonstrated that the frequency of cytomegalovirus-specific T cells was enriched five-fold in CD4hi CD8alphalo T cells compared to single-positive CD4+ T cells, whereas no consistent enrichment was observed for simian immunodeficiency virus (SIV)-specific T cells. Cross-sectional studies of SIV-infected animals demonstrated that the frequency of CD4hi CD8alphalo T cells was lower in wild-type SIV-infected animals compared to uninfected controls, although prospective studies of SIV-infected animals demonstrated depletion of CD4hi CD8alphalo lymphocytes only in a subset of animals. Taken together, these data suggest that CD4+ T cells expressing CD8alpha represent an effector/memory subset of CD4+ T cells and that this cell population can be depleted during the course of SIV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16836648      PMCID: PMC1782346          DOI: 10.1111/j.1365-2567.2006.02428.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

Authors:  M A Suni; S A Ghanekar; D W Houck; H T Maecker; S B Wormsley; L J Picker; R B Moss; V C Maino
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

2.  A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

Authors:  R D Salter; R J Benjamin; P K Wesley; S E Buxton; T P Garrett; C Clayberger; A M Krensky; A M Norment; D R Littman; P Parham
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

3.  Persistent expansions of CD4+ CD8+ peripheral blood T cells.

Authors:  P Sala; E Tonutti; C Feruglio; F Florian; A Colombatti
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

4.  Emergence of double-positive CD4/CD8 cells from adult peripheral blood mononuclear cells infected with human T cell leukemia virus type I (HTLV-I).

Authors:  B Macchi; G Graziani; J Zhang; A Mastino
Journal:  Cell Immunol       Date:  1993-07       Impact factor: 4.868

5.  Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.

Authors:  Z Chen; P Zhou; D D Ho; N R Landau; P A Marx
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Effects of SIVmac infection on peripheral blood CD4+CD8+ T lymphocytes in cynomolgus macaques.

Authors:  H Akari; K H Nam; K Mori; I Otani; H Shibata; A Adachi; K Terao; Y Yoshikawa
Journal:  Clin Immunol       Date:  1999-06       Impact factor: 3.969

7.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 8.  Porcine peripheral blood CD4+/CD8+ dual expressing T-cells.

Authors:  M D Pescovitz; A G Sakopoulos; J A Gaddy; R J Husmann; F A Zuckermann
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

9.  The human Lyt-3 molecule requires CD8 for cell surface expression.

Authors:  J P DiSanto; R W Knowles; N Flomenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  11 in total

1.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Authors:  R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Michelle Connole; R Paul Johnson
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

2.  Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.

Authors:  Agne Taraseviciute; Victor Tkachev; Rafael Ponce; Cameron J Turtle; Jessica M Snyder; H Denny Liggitt; David Myerson; Luis Gonzalez-Cuyar; Audrey Baldessari; Chris English; Alison Yu; Hengqi Zheng; Scott N Furlan; Daniel J Hunt; Virginia Hoglund; Olivia Finney; Hannah Brakke; Bruce R Blazar; Carolina Berger; Stanley R Riddell; Rebecca Gardner; Leslie S Kean; Michael C Jensen
Journal:  Cancer Discov       Date:  2018-03-21       Impact factor: 39.397

3.  High content cellular immune profiling reveals differences between rhesus monkeys and men.

Authors:  Isabelle Magalhaes; Nalini K Vudattu; Raija K Ahmed; Sharon Kühlmann-Berenzon; Yen Ngo; Donata R Sizemore; Lena Wehlin; Frank Weichold; Jan Andersson; Yasir A W Skeiky; Jerry Sadoff; Hans Gaines; Rigmor Thorstensson; Mats Spångberg; Markus J Maeurer
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

4.  CD4+ CD8+ T cells in young and elderly humans. Comment on Macchia I, Gauduin MC, Kaur A, Johnson RP. Expression of CD8alpha identifies a distinct subset of effector memory CD4 T lymphocytes. Immunology 2006; 119:232-42.

Authors:  Dietmar Herndler-Brandstetter; Angelika Schwanninger; Beatrix Grubeck-Loebenstein
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

Review 5.  Memory T cells in Rhesus macaques.

Authors:  Monica Vaccari; Genoveffa Franchini
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.

Authors:  Chaman Saini; H K Prasad; Rajni Rani; A Murtaza; Namita Misra; N P Shanker Narayan; Indira Nath
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

7.  Vaccination with SIVmac239Deltanef activates CD4+ T cells in the absence of CD4 T-cell loss.

Authors:  R K Reeves; J Gillis; F E Wong; R P Johnson
Journal:  J Med Primatol       Date:  2009-10       Impact factor: 0.667

Review 8.  Rhesus CMV: an emerging animal model for human CMV.

Authors:  Colin Powers; Klaus Früh
Journal:  Med Microbiol Immunol       Date:  2008-01-11       Impact factor: 3.402

9.  CD8 T cell response maturation defined by anentropic specificity and repertoire depth correlates with SIVΔnef-induced protection.

Authors:  Sama Adnan; Arnaud D Colantonio; Yi Yu; Jacqueline Gillis; Fay E Wong; Ericka A Becker; Michael Piatak; R Keith Reeves; Jeffrey D Lifson; Shelby L O'Connor; R Paul Johnson
Journal:  PLoS Pathog       Date:  2015-02-17       Impact factor: 6.823

10.  Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.

Authors:  Sama Adnan; R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Jeremy V Camp; Qingsheng Li; Michelle Connole; Yuan Li; Michael Piatak; Jeffrey D Lifson; Wenjun Li; Brandon F Keele; Pamela A Kozlowski; Ronald C Desrosiers; Ashley T Haase; R Paul Johnson
Journal:  PLoS Pathog       Date:  2016-12-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.